• Dual-Action Inhibitors Accelerate p38α Dephosphorylation

  2026-09-02

  The reference study shows that selected p38α MAP kinase inhibitors can both suppress catalytic activity and increase WIP1-mediated removal of the activation-loop phosphothreonine. Structural comparisons explain this effect and suggest that controlling kinase conformation may improve the durability and selectivity of kinase-directed inhibition.

• Epacadostat (INCB024360) Workflow Guide

  2026-09-01

  Build a reproducible IDO1 inhibition workflow by combining Epacadostat dose–response testing with standardized whole-blood stimulation, kynurenine tracking, and immune-function readouts. The approach helps distinguish direct metabolic blockade from donor, cytokine, or checkpoint-combination effects in immuno-oncology research.

• Angiotensin Peptides and SARS-CoV-2 Spike Binding

  2026-09-01

  Oliveira and colleagues show that naturally occurring angiotensin fragments can alter SARS-CoV-2 spike-protein binding to AXL, ACE2, and NRP1 in receptor-binding assays. The work identifies peptide length, N-terminal sequence, and tyrosine modification as important determinants, while indicating that the findings remain an in vitro biochemical observation rather than evidence of altered infection or clinical risk.

• Calcitriol: Designing VDR Mechanism Studies

  2026-08-31

  Calcitriol, also called 1,25-dihydroxy vitamin D3, is more than a vitamin D metabolite: it is a precise probe for time-dependent VDR biology. This guide explains how to design, interpret, and troubleshoot mechanistic assays across decidualization, immune modulation, and cancer research.

• circCHSY1–HO1 Signaling in Cardiac I/R Injury

  2026-08-30

  The reference study identifies circCHSY1 as an endogenous protective response to myocardial ischaemia/reperfusion injury and defines a circCHSY1–miR-24-3p–HO1 regulatory axis. Its combination of mouse, primary cardiomyocyte, and human embryonic stem-cell-derived cardiomyocyte models links this pathway to infarct limitation, cell survival, and mitochondrial homeostasis.

• THZ1: Covalent CDK7 Inhibitor Workflow

  2026-08-29

  THZ1 enables time-resolved studies of CDK7-dependent transcription, with particular value in T-ALL, cancer-cell proliferation, and apoptosis workflows. Its irreversible covalent mechanism supports pulse-washout experiments that complement conventional endpoint viability assays.

• HMGCS2–LysoPC Signaling in Pulmonary Fibrosis

  2026-08-29

  Yang et al. show that injured type II alveolar epithelial cells are a major source of accumulated lysophosphatidylcholine in experimental pulmonary fibrosis and that these lipids activate lung fibroblasts. Their data connect epithelial HMGCS2 loss to impaired lipid degradation through a PPARα–CPT1A/CPT2 axis, creating a mechanistic framework for lipid signaling pathway analysis and fibrosis research.

• Palbociclib as a Cell-Cycle Control for DNA Repair Assays

  2026-08-28

  Palbociclib and PD0332991 are more than CDK4/6 pathway probes: they can help researchers separate cell-cycle state from DNA-repair phenotypes. This article presents an assay-focused framework linking G0/G1 arrest, p53-dependent platinum response, and practical cancer-biology controls.

• Chenodeoxycholic Acid: From FXR to Assay Design

  2026-08-28

  Chenodeoxycholic Acid is more than an FXR agonist: it is a useful mechanistic probe for connecting bile acid metabolism with transcriptional and inflammatory phenotypes. This guide translates recent FXR–KLF11 findings into practical assay-design decisions, controls, and interpretation limits.

• How Near-Death Cells Seed a Prometastatic State

  2026-08-27

  Conod, Silvano, and Ruiz i Altaba identify a mechanism in which tumor cells surviving impending death become stable prometastatic cells, termed PAMEs. Their work links ER stress, PERK–CHOP signaling, GLI and NANOG-associated reprogramming, and a cytokine storm to metastatic dissemination, while showing that PAMEs recruit neighboring PIM cells to build a prometastatic ecosystem.

• IRF3 Autophagy Balances Antiviral Immunity

  2026-08-27

  The reference study identifies CALCOCO2/NDP52-mediated selective autophagy as a virus-load-dependent mechanism that limits IRF3 stability. It further shows that PSMD14 preserves basal IRF3 by removing K27-linked ubiquitin chains at lysine 313, revealing how ubiquitin editing and autophagic turnover tune type I interferon responses.

• AG-120 and the Metabolic Logic of IDH1-Mutant AML

  2026-08-26

  AG-120 (Ivosidenib) lowers the oncometabolite 2-hydroxyglutarate by selectively inhibiting mutant IDH1, creating a mechanistic bridge between metabolic correction and myeloid differentiation. New findings on CD44-driven NADPH production suggest how translational researchers can use AG-120 to test combination strategies, resistance biology, and pharmacodynamic depth in IDH1-mutant leukemia.

• Ferrostatin-1 Workflows for Ferroptosis Assays

  2026-08-26

  Ferrostatin-1 (Fer-1) provides a practical rescue control for distinguishing lipid peroxidation-driven cell death from nonspecific toxicity. This workflow translates evidence from cisplatin-induced acute kidney injury into reproducible assay design for cancer biology research, neuronal models, and oxidative injury studies.

• CGRP Restrains CD4+ T Cells in Allergic Sensitization

  2026-08-25

  Li et al. identify a sensory-neuron-to-T-cell pathway in which CGRP signaling through RAMP1 directly limits CD4+ T-cell activation, Tfh accumulation, and allergic sensitization. By combining genetic models, lymph-node imaging, TCR-seq, parabiosis, adoptive transfer, transcriptomics, and ATAC-seq, the study connects neuropeptide signaling with chromatin and transcriptional control of adaptive immunity.

• Bestatin Enhances Endothelial Invasion in Fibrin

  2026-08-25

  The 2003 reference study showed that Bestatin, previously associated with anti-angiogenic activity, instead increased microvascular endothelial cell invasion and capillary-like tube formation in a fibrin matrix. Its dose- and matrix-dependent behavior indicates that CD13 inhibition alone does not explain the response and that fibrin degradation must be considered when interpreting angiogenesis assays.

451 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page